GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Net Margin %

Next Science (ASX:NXS) Net Margin % : -51.99% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Next Science Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Next Science's Net Income for the six months ended in Jun. 2024 was A$-8.80 Mil. Next Science's Revenue for the six months ended in Jun. 2024 was A$16.93 Mil. Therefore, Next Science's net margin for the quarter that ended in Jun. 2024 was -51.99%.

The historical rank and industry rank for Next Science's Net Margin % or its related term are showing as below:

ASX:NXS' s Net Margin % Range Over the Past 10 Years
Min: -353.38   Med: -108.28   Max: -57.91
Current: -57.91


ASX:NXS's Net Margin % is ranked worse than
84.74% of 996 companies
in the Drug Manufacturers industry
Industry Median: 3.955 vs ASX:NXS: -57.91

Next Science Net Margin % Historical Data

The historical data trend for Next Science's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Net Margin % Chart

Next Science Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -353.38 -346.15 -104.49 -108.28 -73.36

Next Science Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -121.77 -96.71 -85.17 -63.46 -51.99

Competitive Comparison of Next Science's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Science's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's Net Margin % distribution charts can be found below:

* The bar in red indicates where Next Science's Net Margin % falls into.



Next Science Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Next Science's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-24.309/33.135
=-73.36 %

Next Science's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-8.8/16.926
=-51.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Next Science  (ASX:NXS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Next Science Net Margin % Related Terms

Thank you for viewing the detailed overview of Next Science's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Next Science Business Description

Traded in Other Exchanges
Address
264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.

Next Science Headlines

No Headlines